Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer.
<h4>Background</h4>Ampulla of Vater cancer (AoV Ca) is a rare tumor, and its adjuvant treatment has not been established. The purpose of this study was to find out prognostic factors including host immunity and role of adjuvant treatment in AoV Ca.<h4>Methods and findings</h4>...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
Public Library of Science (PLoS)
2016-01-01
|
| סדרה: | PLoS ONE |
| גישה מקוונת: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0151406&type=printable |